Titre:
  • Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
Auteur:Di Santo, E.; Sironi, Marina; Pozzi, P.; Gnocchi, P.; Isetta, AM; Delvaux, Annie; Goldman, Michel; Marchant, Arnaud; Ghezzi, P.
Informations sur la publication:Neuroimmunomodulation, 2, 3, page (149-154)
Statut de publication:Publié, 1995
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Animals
Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- immunology
Antibodies, Monoclonal -- pharmacology
Brain -- drug effects
Brain -- metabolism
Corticosterone -- blood
Endotoxins -- pharmacology
Feedback
Gene Expression Regulation -- drug effects
Hypothalamo-Hypophyseal System -- physiology
Injections, Intraventricular
Interleukin-1 -- biosynthesis
Interleukin-1 -- genetics
Interleukin-10 -- antagonists & inhibitors
Interleukin-10 -- immunology
Interleukin-10 -- pharmacology
Lipopolysaccharides -- pharmacology
Male
Mice
Pituitary-Adrenal System -- physiology
Recombinant Proteins -- pharmacology
Serum Amyloid A Protein -- biosynthesis
Serum Amyloid A Protein -- genetics
Tumor Necrosis Factor-alpha -- biosynthesis
Tumor Necrosis Factor-alpha -- genetics
Note générale:Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1021-7401
info:doi/10.1159/000096885
info:scp/0028789395
info:pmid/8646564